Optimizing Treatment of Stage IV Breast Cancer Through Real-Time Disease Monitoring

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1. 1This trial is listed as suspended — can you find out why it was suspended and whether that affects the reliability or usefulness of any data that's already been collected from it?
2. 2This study focuses on monitoring circulating tumor DNA in the blood to detect treatment failure early — is ctDNA monitoring something that could be relevant to my own care right now, even outside of this specific trial?
3. 3Since this trial is measuring ctDNA fractions above 50% as a key marker, what does it mean for my prognosis or treatment planning if my ctDNA levels are high, and is that something we could test for?
4. 4Given that this is listed as Phase NA and is currently suspended, are there other active trials studying real-time disease monitoring or liquid biopsy approaches for Stage IV breast cancer that might be worth considering instead?
5. 5If ctDNA testing shows signs of treatment failure earlier than standard imaging, how would that actually change the treatment decisions we'd make together — and is that approach already used in your practice?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.